Protext Mobility Inc. has launched a new corporate website and investor relations platform to highlight its strategic growth in biotechnology, pharmaceutical infrastructure, and digital financial systems. The company is focused on building scalable infrastructure that bridges biological production, pharmaceutical-grade outputs, and digital capital markets. Recent international engagements, including a Letter of Intent with the Venezuelan government, underscore its expanding global partnerships. Protext aims to uplist its shares and continue advancing scientific innovation and institutional frameworks to support long-term shareholder value.
Celldex Therapeutics presented long-term Phase 2 results showing barzolvolimab provides rapid, significant, and durable relief from angioedema in patients with moderate to severe chronic spontaneous urticaria (CSU) refractory to antihistamines. Impre...
Kraken has introduced BTC Vault, a new product that allows Bitcoin holders to earn rewards directly in BTC through on-chain lending without needing DeFi expertise or external wallets. This service targets long-term holders who want to generate yield ...
Dogecoin has stabilized near $0.088 after a recent drop to $0.078, supported by over 200 million DOGE accumulated by large investors around $0.081. Technical analysis highlights a repeating triangle apex retest pattern, similar to setups before major...
Genuine Parts, a leader in automotive and industrial parts distribution, raised its dividend for the 70th consecutive year, reflecting stable demand driven by aging vehicles and urgent repair needs. The company reported Q1 2026 revenue growth of 6.8%...
The Schwab U.S. Dividend Equity ETF (SCHD) is popular for low-cost, value-tilted dividend investing with quarterly payouts. However, the WisdomTree U.S. Quality Dividend Growth Fund (DGRW) provides monthly dividends, a focus on quality dividend growe...
